Keiko Tanaka

Dr. Keiko Tanaka


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YOYasuhiro Onishi
Yasuhiro Onishi
Haruhito A. UchidaHaruhito A. Uchida
Haruhito A. Uchida
YMYohei Maeshima
Yohei Maeshima
YOYuka Okuyama
Yuka Okuyama
NONozomu Otaka
Nozomu Otaka
JWJun Wada
Jun Wada
Introduction: While chronic kidney disease (CKD) is one of the most important contributors to mortality from non-communicable diseases, the number of nephrologists is limited worldwide. Medical cooperation is a system of cooperation between primary care physicians and nephrological institutions, consisting of nephrologists and multidisciplinary care teams. Although it has been reported that multidisciplinary care teams contribute to the prevention of worsening renal functions and cardiovascular events, there are few studies on the effect of a medical cooperation system. Methods: We aimed to evaluate the effect of medical cooperation on all-cause mortality and renal prognosis in patients with CKD. One hundred and sixty-eight patients who visited the one hundred and sixty-three clinics and seven general hospitals of Okayama city were recruited between December 2009 and September 2016, and one hundred twenty-three patients were classified into a medical cooperation group. The outcome was defined as the incidence of all-cause mortality, or renal composite outcome (end-stage renal disease or 50% eGFR decline). We evaluated the effects on renal composite outcome and pre-ESRD mortality while incorporating the competing risk for the alternate outcome into a Fine–Gray subdistribution hazard model. Results: The medical cooperation group had more patients with glomerulonephritis (35.0% vs. 2.2%) and less nephrosclerosis (35.0% vs. 64.5%) than the primary care group. Throughout the follow-up period of 5.59 ± 2.78 years, 23 participants (13.7%) died, 41 participants (24.4%) reached 50% decline in eGFR, and 37 participants (22.0%) developed end-stage renal disease (ESRD). All-cause mortality was significantly reduced by medical cooperation (sHR 0.297, 95% CI 0.105–0.835, p = 0.021). However, there was a significant association between medical cooperation and CKD progression (sHR 3.069, 95% CI 1.225–7.687, p = 0.017). Conclusion: We evaluated mortality and ESRD using a CKD cohort with a long-term observation period and concluded that medical cooperation might be expected to influence the quality of medical care in the patients with CKD.

Verified
Journal Article
Open access
PDF file
KTKeiko Tanaka
Keiko Tanaka
HSHitoshi Sugiyama
Hitoshi Sugiyama
HMHiroshi Morinaga
Hiroshi Morinaga
MKMasashi Kitagawa
Masashi Kitagawa
YKYuzuki Kano
Yuzuki Kano
JWJun Wada
Jun Wada
Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant cytokines, which were associated with clinical parameters and histological scores in IgAN patients. Results: Among 15 cytokines, the levels of soluble CD40L (sCD40L) and IL-31 were higher in IgAN patients and were significantly associated with a higher estimated glomerular filtration rate (eGFR), a lower urinary protein to creatinine ratio (UPCR), and milder tubulointerstitial lesions (i.e., the early phase of IgAN). Multivariate analysis revealed that serum sCD40L was an independent determinant of a lower UPCR after adjustment for age, eGFR, and mean blood pressure (MBP). CD40, a receptor of sCD40L, has been reported to be upregulated on mesangial cells in IgAN. The sCD40L/CD40 interaction may directly induce inflammation in mesangial areas and may therefore be involved in the development of IgAN. Conclusions: The present study demonstrated the significance of serum sCD40L and IL-31 in the early phase of IgAN. Serum sCD40L may be a marker of the beginning of inflammation in IgAN.

24 January 2026 in CEN Case Reports
Verified
Journal Article
Closed access
PDF file
NUNaruhiko Uchida
Naruhiko Uchida
KTKeiko Tanaka
Keiko Tanaka
NKNatsuki Kubota
Natsuki Kubota
TKTakayuki Katsuyama
Takayuki Katsuyama
KTKatsuyuki Tanabe
Katsuyuki Tanabe
JWJun Wada
Jun Wada

22 July 2026 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
KKKatsuyoshi Katayama
Katsuyoshi Katayama
Haruhito A. UchidaHaruhito A. Uchida
Haruhito A. Uchida
TNToshihiko Nagao
Toshihiko Nagao
JEJun Eguchi
Jun Eguchi
Kenji TsujiKenji Tsuji
Kenji Tsuji
JWJun Wada
Jun Wada
Aims: This study aimed to evaluate the clinical efficacy of SD‐ΔRR as a novel methodology for short‐duration heart rate variability (HRV) assessment for the diagnosis of diabetic sensorimotor polyneuropathy (DSPN) in patients with diabetes. Materials and Methods: Participants were assigned into normal fasting glucose (NFG) and diabetes groups. Patients with diabetes were further classified as patients with and without DSPN. Electrocardiograms were recorded at rest, during standing, and during deep breathing to evaluate HRV parameters. HRV was statistically compared between the groups. Results: A total of 103 patients with diabetes (18 with DSPN, 85 without) and 52 with NFG were included in the analysis. SD‐ΔRR values were comparable between the diabetes and NFG groups. However, among patients with diabetes, patients with DSPN had significantly lower SD‐ΔRRs than patients without DSPN ( P < 0.05). Despite being age‐ and sex‐matched, patients with DSPN had a significantly higher prevalence of hypertension and advanced chronic kidney disease than those without DSPN. Logistic regression analysis demonstrated that SD‐ΔRRs during standing and deep breathing were significantly associated with the presence of DSPN in patients with diabetes ( P < 0.05 each). After adjustment for confounding factors, only SD‐ΔRR during standing remained statistically significant. The cutoff value for SD‐ΔRR during standing showed high sensitivity (83%), whereas that during deep breathing demonstrated high specificity (84%) for diagnosis of DSPN. Conclusions: SD‐ΔRR may serve as a clinically informative parameter for identifying DSPN in patients with diabetes. In combination with physical stressors, this metric offers distinct diagnostic advantages with high sensitivity and specificity.